Literature DB >> 11434570

Antimalarials--the 'real' advance in lupus.

D J Wallace1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11434570     DOI： 10.1191/096120301678646092

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  15 in total

Review 1.  Current and novel therapeutics in the treatment of systemic lupus erythematosus.

Authors:  Cagri Yildirim-Toruner; Betty Diamond
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

Review 2.  New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

Authors:  Daniel J Wallace; Vineet S Gudsoorkar; Michael H Weisman; Swamy R Venuturupalli
Journal:  Nat Rev Rheumatol       Date:  2012-07-17       Impact factor: 20.543

3.  Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.

Authors:  Gabriela Schmajuk; Jinoos Yazdany; Laura Trupin; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

4.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).

Authors:  Graciela S Alarcón; Gerald McGwin; Ana M Bertoli; Barri J Fessler; Jaime Calvo-Alén; Holly M Bastian; Luis M Vilá; John D Reveille
Journal:  Ann Rheum Dis       Date:  2007-03-27       Impact factor: 19.103

Review 5.  Drugs in early clinical development for Systemic Lupus Erythematosus.

Authors:  Mariana Postal; Nailú Angélica Sinicato; Simone Appenzeller; Timothy B Niewold
Journal:  Expert Opin Investig Drugs       Date:  2016-04-07       Impact factor: 6.206

6.  Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).

Authors:  R M Andrade; G S Alarcón; L A González; M Fernández; M Apte; L M Vilá; G McGwin; J D Reveille
Journal:  Ann Rheum Dis       Date:  2007-09-17       Impact factor: 19.103

7.  Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution.

Authors:  Paula I Burgos; Elizabeth L Perkins; Guillermo J Pons-Estel; Scott A Kendrick; Jigna M Liu; William T Kendrick; William J Cook; Bruce A Julian; Graciela S Alarcón; Clifton E Kew
Journal:  Arthritis Rheum       Date:  2009-09

8.  Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Gerald McGwin; Maria I Danila; Jie Zhang; Holly M Bastian; John D Reveille; Luis M Vilá
Journal:  Arthritis Rheum       Date:  2009-06-15

9.  Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview.

Authors:  Elias Toubi; Aharon Kessel; Ellen Bamberger; Theo Dov Golan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

Review 10.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.